Index
Module 4 • Quality & Safety
Protocol Development & Quality Improvement
95%
Core Content
Protocol Development & Quality Improvement
Jaime Robenolt Gray ~2 min read Module 4 of 20
42
/ 44

Protocol Development and Quality Improvement

6

Answer: D

Because the data have already been collected, they

must be analyzed to determine the baseline time to

antibiotics (Answer D is correct). The measuring

phase includes collecting the data, which has already

been completed (Answer A is incorrect). Establishing

methods is part of the design (Answer B is incorrect).

The change process being implemented is the

improvement phase (Answer C is incorrect).

7

Answer: A

Using weighted metrics for each critical care pharmacist

activity – quantified over time and annualized – more

accurately quantifies a critical care pharmacist’s

activities (Answer A is correct). The number of cardiac

arrest codes attended each month, number and severity

of hospital-acquired Clostridioides difficile infections

each year, and the number of in-services provided each

year are important, but do not quantify a comprehensive

list of a critical care pharmacist’s activities individually

(Answers B, C, and D are incorrect).

8

Answer: A

Sepsis management bundle and VTE prophylaxis

are quality measures reported to CMS (Answer A is

correct). Thrombolytic therapy for patients with stroke

is correct, but stress ulcer prophylaxis is not reported

(Answer B is incorrect). Heart failure readmissions

are reported, but pneumonia vaccination rates are not

(Answer C is incorrect). Use of ventilator bundles is

not reported, but rates of acute coronary syndrome

readmission are reported (Answer D is incorrect).

Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 41 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube